Investor Alert

New York Markets Open in:

Market Pulse Archives

June 7, 2019, 8:57 a.m. EDT

Cancer genomics company Personalis expects to raise up to $107 million in IPO

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Personalis Inc. (PSNL)
  • X
    iShares Nasdaq Biotechnology ETF (IBB)
  • X
    Renaissance IPO ETF (IPO)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Personalis Inc. /zigman2/quotes/212754973/composite PSNL -14.29% disclosed Friday terms of its initial public offering, in which the cancer genomics company could raise up to $106.7 million, and be valued at up to about $456 million. The company said it was offering 6,666,667 shares in the IPO, which is expected to price between $14 and $16 a share, and will have about 28.5 million shares outstanding after the offering. Personalis plans to use the IPO proceeds for the expansion of research and development, infrastructure, facilities, headcount, marketing spend and other capital expenditures. The stock is expected to list on the Nasdaq exchange under the ticker symbol "PSNL." The lead underwriters of the IPO are Morgan Stanley, BofA Merrill Lynch and Cowen. The company recorded a 2018 net loss of $19.9 million on revenue of $37.8 million, after a loss of $23.6 million on revenue of $9.4 million in 2017. Personalis is looking to go public at a time the iShares Nasdaq Biotechnology ETF /zigman2/quotes/206189322/composite IBB -1.79% has lost 6.4% over the past three months, while the both the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO -1.57% and the S&P 500 /zigman2/quotes/210599714/realtime SPX -1.04% have gained 3.4%.

US : U.S.: Nasdaq
$ 19.50
-3.25 -14.29%
Volume: 1.44M
May 10, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$998.92 million
Rev. per Employee
US : U.S.: Nasdaq
$ 147.03
-2.68 -1.79%
Volume: 3.41M
May 10, 2021 4:00p
US : U.S.: NYSE Arca
$ 55.33
-0.88 -1.57%
Volume: 462,192
May 10, 2021 4:00p
-44.17 -1.04%
Volume: 2.32B
May 10, 2021 5:40p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.